Get the Full Story, Without the Noise.
Get Started
SubscribeLogin
Israel-Hamas Conflict
India Economy
Artificial Intelligence
Heatwaves
Social Media
World Cup
South America
Stock Markets
United Nations
Taxes
European Union
Donald Trump
Instagram
Published • loading... • Updated

Breakthrough in Rare Liver Disease: CAM2029 Trial Reduces Cyst Volume by 8.7% in Untreated Condition

Summary by stocktitan.net
Phase 2b POSITANO study demonstrates efficacy in treating polycystic liver disease. First potential treatment shows promising liver volume reduction. See full results.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
stocktitan.netstocktitan.net

Breakthrough in Rare Liver Disease: CAM2029 Trial Reduces Cyst Volume by 8.7% in Untreated Condition

Phase 2b POSITANO study demonstrates efficacy in treating polycystic liver disease. First potential treatment shows promising liver volume reduction. See full results.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Wednesday, June 18, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Positano icon

Positano

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal